Differential Diagnoses for a Positive DAT Scan
A positive (abnormal) DAT scan indicates presynaptic dopaminergic neuronal loss and confirms the presence of neurodegenerative parkinsonism, which includes Parkinson's disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). 1
Primary Neurodegenerative Parkinsonian Syndromes
A positive DAT scan demonstrates abnormal patterns of dopaminergic depletion in all of the following conditions 1:
Parkinson's Disease (PD)
- Most common cause of parkinsonism (incidence 10-18/100,000)
- Peak onset 60-70 years
- Classic triad: resting tremor, bradykinesia, rigidity
- Synucleinopathy with Lewy body deposition
- DAT scan shows decreased uptake in striatum, typically posterior-to-anterior gradient (putamen → caudate)
- Asymmetric involvement common (~28% lower DAT availability on more-affected side) 2
Multiple System Atrophy (MSA)
- Onset typically 55-65 years, mean disease duration ~6 years
- Three subtypes:
- MSA-P (striatonigral degeneration): Parkinsonian features predominate
- MSA-C (olivopontocerebellar atrophy): Cerebellar ataxia predominates
- MSA-A (Shy-Drager syndrome): Autonomic dysfunction predominates
- Synucleinopathy with oligodendroglial cytoplasmic inclusions
- Additional features: cerebellar ataxia, pyramidal signs, dysautonomia (urinary incontinence)
- DAT scan shows abnormal dopaminergic depletion pattern 1
Progressive Supranuclear Palsy (PSP)
- Most common atypical parkinsonism (prevalence ~5/100,000)
- Mean onset age 63 years
- Tauopathy with abnormal tau protein accumulation
- Classic presentation: lurching gait, axial dystonia, unexplained falls
- Vertical supranuclear gaze palsy (typically late finding)
- Early ocular symptoms: blurred vision, slow saccades
- DAT scan demonstrates abnormal dopaminergic depletion 1
Corticobasal Degeneration (CBD)
- Onset 50-70 years
- Tauopathy
- Asymmetric limb clumsiness progressing to unilateral limb rigidity and dystonia
- "Alien limb phenomenon"
- Cortical features: apraxia, cortical dementia, cortical sensory deficits, impaired language
- Important caveat: CBD exhibits relatively mild DAT scan abnormalities compared to other parkinsonian syndromes 3
- Mean striatum binding index >2.04 can differentiate CBD from MSA-P (sensitivity 70.4%, specificity 86.7%) 3
Critical Distinctions
What DAT Scan CANNOT Differentiate:
The DAT scan cannot reliably distinguish between PD, MSA, and PSP as all show abnormal dopaminergic depletion 3, 4. Additional clinical features and advanced MRI are needed for this differentiation 1.
Quantitative Patterns May Help:
- CBD vs PSP: Mean striatum BSI >1.95 (sensitivity 74.1%, specificity 85.0%) 3
- CBD vs PD: Mean striatum BSI >2.11 (sensitivity 66.7%, specificity 100%) 3
- CBD generally shows less severe DAT abnormalities than other parkinsonian syndromes 3
Clinical Utility
A positive DAT scan confirms neurodegenerative parkinsonism but requires clinical correlation and often additional imaging (MRI, FDG-PET) to distinguish among the specific syndromes. 1 The scan demonstrates abnormality early in disease course, often before conventional MRI shows changes 1.
Key Clinical Correlates:
- DAT availability in putamen and substantia nigra correlates negatively with motor severity (r = -0.59 for putamen, r = -0.46 for substantia nigra) 2
- Asymmetry index correlates with motor asymmetry (r = -0.60) 2
- Longitudinal reduction in DAT availability strongly correlates with motor progression (r = 0.91) 2
Common Pitfall:
Do not assume a positive DAT scan automatically means idiopathic PD—it confirms dopaminergic neuronal loss but requires integration with clinical features, disease progression patterns, and additional imaging to determine the specific parkinsonian syndrome 1.